{"id":16995,"date":"2014-03-11T08:30:04","date_gmt":"2014-03-11T12:30:04","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=16995"},"modified":"2014-03-11T08:16:09","modified_gmt":"2014-03-11T12:16:09","slug":"regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995","title":{"rendered":"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 03\/11\/2014 (wallstreetpr) &#8211; <b>Regado Biosciences Inc. (NASDAQ:RGDO) <\/b>was one of the top gainers on Monday trading session after announcing that the US Food and Drug Administration had designated its REG 1 for anticoagulant therapy which is to be used for patients suffering from coronary artery disease. REG 1 can be used during coronary interventions as one of the most effective Fast track development program.<\/p>\n<p style=\"text-align: justify;\">The FDA first track process aims at expediting the review of drugs to be used in the treatment of various serious conditions that fill unmet medical needs. This process will target, getting as many drugs as possible to patients. REG 1 drug is being prepared for the late stage development as it gears up for phase 3 trial.<\/p>\n<p style=\"text-align: justify;\">Regado Biosciences Inc. (NASDAQ:RGDO)<b> <\/b>has been surging in the market over the past month as it continues to receive positive reception from the FDA on its latest drugs to the market. February saw Regado Biosciences receive the approval from FDA for the investigational new drug IND for REG 2. The pill has potential uses in a wide range of cardiovascular conditions such as thromboembolism prophylaxis especially in patients undergoing abdominal surgery.<\/p>\n<p style=\"text-align: justify;\">Regado Biosciences Inc. (NASDAQ:RGDO)\u2019s<b> <\/b>Chief Executive officer David J Mazzo was buoyed by the latest approval by the FDA as the company continues to believe that REG1 will become the new standard of care for anticoagulation in intervention cardiology. The chief also pointed out that the Phase 3 Regulate-PCI study is ongoing aimed at bringing the new therapy to patients as soon as possible.<\/p>\n<p style=\"text-align: justify;\">REG1 stands to offer clinical meaningful advantage against the currently used therapies if it meets its primary endpoints. The therapy will be more than able to offer control anticoagulation during PCI<\/p>\n<p style=\"text-align: justify;\"><b>Regado Biosciences to report Fourth quarter and full year results<\/b><\/p>\n<p style=\"text-align: justify;\">Regado Biosciences has announced it will be reporting its fourth quarter and full year results for 2013 on a conference call on March 13, 2014 at 8:30 a.m. EDT<\/p>\n<p style=\"text-align: justify;\">Regado Biosciences Inc. (NASDAQ:RGDO)<b> <\/b>surged in Monday trading sessions by highs of 38.14% to close the day at high trading margins of $11.30.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 03\/11\/2014 (wallstreetpr) &#8211; Regado Biosciences Inc. (NASDAQ:RGDO) was one of the top gainers on Monday trading session after announcing that the US Food [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":17006,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[5055,5054],"stock_ticker":[],"class_list":["post-16995","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqrgdo","tag-regado-biosciences-inc-nasdaqrgdo","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1 - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1 - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 03\/11\/2014 (wallstreetpr) &#8211; Regado Biosciences Inc. (NASDAQ:RGDO) was one of the top gainers on Monday trading session after announcing that the US Food [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-03-11T12:30:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"249\" \/>\n\t<meta property=\"og:image:height\" content=\"166\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1\",\"datePublished\":\"2014-03-11T12:30:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995\"},\"wordCount\":355,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg\",\"keywords\":[\"NASDAQ:RGDO\",\"Regado Biosciences Inc. (NASDAQ:RGDO)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995\",\"name\":\"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg\",\"datePublished\":\"2014-03-11T12:30:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg\",\"width\":249,\"height\":166},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1 - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995","og_locale":"en_US","og_type":"article","og_title":"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1 - Wall Street PR","og_description":"Boston, MA 03\/11\/2014 (wallstreetpr) &#8211; Regado Biosciences Inc. (NASDAQ:RGDO) was one of the top gainers on Monday trading session after announcing that the US Food [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-03-11T12:30:04+00:00","og_image":[{"width":249,"height":166,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1","datePublished":"2014-03-11T12:30:04+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995"},"wordCount":355,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg","keywords":["NASDAQ:RGDO","Regado Biosciences Inc. (NASDAQ:RGDO)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995","url":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995","name":"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg","datePublished":"2014-03-11T12:30:04+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Regado-Biosciences-Inc..jpg","width":249,"height":166},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/regado-biosciences-inc-nasdaqrgdo-announces-fda-approval-for-reg-1-16995#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Regado Biosciences Inc. (NASDAQ:RGDO) Announces FDA Approval For REG 1"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/16995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=16995"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/16995\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/17006"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=16995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=16995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=16995"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=16995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}